September 22, 2020 Sophia Vida
Biotech & Pharma

Illumina Says it Will Purchase Bezos-Backed Grail for $8B

Illumina, a global leader in genomics, announced this week that it will be acquiring the remaining stake in Jeff Bezos-backed gene-sequencing company Grail that it doesn’t already own for $8 billion in cash and stock. The early stage cancer-detection healthcare company, backed by Amazon CEO Jeff Bezos, said that it will acquire Grail for $3.5 … Continue reading “Illumina Says it Will Purchase Bezos-Backed Grail for $8B”